Scepticism is festering among some market watchers about the merits of consumer giant Reckitt Benckiser's (RB.) mooted $16.7bn (£13.5bn) takeover of infant formula business Mead Johnson.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis